ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
A Quantitative Framework to Assess the Potential of Earlier Cancer Detection to Improve Cancer Survival.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The impact of multicancer early detection tests on cancer stage shift: A 10-year microsimulation model.Cancer · 2025Article
- Multi-cancer early detection tests: Attributes for clinical implementation.Cancer biomarkers : section A of Disease markers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarlier cancer detection through advancements in screening technologies and increased screening access and adherence may improve cancer survival. We developed a quantitative approach using a matrix equation to characterize cancer stage shift resulting from cancer screening interventions and estimated resulting survival improvements.
methodsThe expected percent survival improvement was defined a priori as 20%, and the analysis sought to characterize the stage shift required to achieve this goal. The matrix equation was populated with incidence and cause-specific survival for 16 cancers by stage at diagnosis using the National Cancer Institute Surveillance, Epidemiology, and End Results database. Linear programming was used to solve for the matrix given a set of constraints formulated to steer the solution toward the least amount of downstaging required to achieve the objective and to partially compensate for length-time bias.
resultsThree common trends emerged across almost all cancer types: (i) Most of the survival improvement can be achieved by detecting disease prior to stage IV; (ii) remaining survival improvements can be achieved by detecting just one stage earlier; and (iii) stage I diagnosis is not necessary to achieve measurable survival improvement goals. Lung cancer required more aggressive earlier detection than others, an expected result as lung cancer has a very high incidence and very poor survival.
conclusionsThis flexible mathematical framework may be helpful for public health officials to characterize how earlier cancer detection can affect cancer survival. IMPACT: Our results suggest that detecting cancer prior to distant metastases may significantly improve survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.